S. Ramagopalan

First name
S.
Middle name
V.
Last name
Ramagopalan
Disanto, G. ., Zecca, C. ., MacLachlan, S. ., Sacco, R. ., Handunnetthi, L. ., Meier, U. C., … Gobbi, C. . (2018). Prodromal symptoms of multiple sclerosis in primary care. Ann Neurol. http://doi.org/10.1002/ana.25247
McDonald, L. ., Schultze, A. ., Carroll, R. ., & Ramagopalan, S. V. (2018). Performing studies using the UK Clinical Practice Research Datalink: to link or not to link?. Eur J Epidemiol. http://doi.org/10.1007/s10654-018-0389-5
Ramagopalan, S. V., Stamp, E. ., Sammon, C. J., Besford, M. ., Carroll, R. ., Mehmud, F. ., & Alikhan, R. . (2019). Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study. Future Cardiol. http://doi.org/10.2217/fca-2019-0012
Allan, V. ., Sammon, C. J., McDonald, L. ., Mehmud, F. ., Alikhan, R. ., & Ramagopalan, S. V. (2019). Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink. Future Cardiol. http://doi.org/10.2217/fca-2019-0025
Ramagopalan, S. V., Carroll, R. ., Ulvestad, M. ., Mehmud, F. ., & Alikhan, R. . (2019). The changing face of venous thromboembolism management in England. Future Cardiol. http://doi.org/10.2217/fca-2019-0003
Schultze, A. ., Graham, S. ., Nordstrom, B. L., Mehmud, F. ., & Ramagopalan, S. V. (2019). Commonly used definitions in real-world studies may underestimate the prevalence of renal disease among nonvalvular atrial fibrillation patients. J Comp Eff Res. http://doi.org/10.2217/cer-2019-0070
Ramagopalan, S. V., Samnaliev, M. ., Weir, S. ., Sammon, C. J., Carroll, R. ., & Alikhan, R. . (2019). Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study. Future Cardiol. http://doi.org/10.2217/fca-2019-0033
Ramagopalan, S. V., Graham, S. ., Carroll, R. ., Raluy-Callado, M. ., Nordstrom, B. L., Donaldson, R. ., … Alikhan, R. . (2019). Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin. J Comp Eff Res. http://doi.org/10.2217/cer-2019-0005
Zecca, C. ., Disanto, G. ., Sacco, R. ., MacLachlan, S. ., Kuhle, J. ., Ramagopalan, S. V., & Gobbi, C. . (2020). Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study. J Neurol. http://doi.org/10.1007/s00415-020-10170-5